Pros | Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | 5Y returns in the bottom 25% of the category. | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. |
INDMoney rank | 8/8 | 6/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 6 Years 7 Months | 13 Years 3 Months | ||
Fund AUM | ₹837 Cr | ₹8265 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 1.02% | 0.92% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 38 | 39 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 98.81% | 97.37% | ||
Debt % | - | - | ||
P/E | 37.68 | 35.17 | ||
P/B | 5.46 | 5.57 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -4.09% | -4.77% | ||
3-Month Return | -6.34% | -6.4% | ||
6-Month Return | -8.07% | -9.62% | ||
1-Year Return | 1.35% | 2.51% | ||
3-Year Return | 21.96% | 21.29% | ||
5-Year Return | 14.81% | 15.66% |
Sharpe | 0.99 | 1.02 | ||
Alpha | -0.67 | -0.2 | ||
Beta | 0.96 | 0.91 | ||
Standard Deviation | 15.86 | 15.11 | ||
Information Ratio | -0.44 | -0.5 |
Description | Aditya Birla Sun Life Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Dhaval Shah | Sailesh Raj Bhan, Divya Sharma, Lokesh Maru, Kinjal Desai |